UK Markets closed

Omeros Corporation (OMER)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.81-0.01 (-0.06%)
At close: 4:00PM EDT
Full screen
Loading interactive chart…
  • Omeros (OMER) Announces Preliminary Data on MASP-3 Inhibitor
    Zacks

    Omeros (OMER) Announces Preliminary Data on MASP-3 Inhibitor

    Omeros (OMER) announces initial results from a phase I study of OMS906.

  • Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction
    Business Wire

    Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction

    Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, immunologic diseases (e.g., complement-mediated diseases and cancers) and central nervous system disorders, today announced publication of the article "Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modu

  • Omeros to Present at the BofA 2021 Napa BioPharma Virtual Conference
    Business Wire

    Omeros to Present at the BofA 2021 Napa BioPharma Virtual Conference

    Omeros Corporation (Nasdaq: OMER), today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the BofA 2021 Napa BioPharma Virtual Conference next week. The fireside chat with Bank of America analyst, Geoff Meacham, PhD, is scheduled for Tuesday, June 15, 2021 at 4:30 p.m. EDT.